Here, we have established the head and neck organoid biobank (HNOB) to address two key aspects: first, to characterize individual and cancer driver-specific tumor characteristics and second, to generate genetically defined TP53/HPV models to address driver-specific consequences on the tumor phenotype and response to radiation therapy. Here, TP53 is linked to neoplasm.